LATEST NEWS

View all +

BLOG: VOICES FROM ACTIVISTS

View all +
  • Brazil to use dolutegravir in first-line HIV treatment

    "The recent announcement that dolutegravir is becoming part of the national HIV program in Brazil is great news for people living with HIV," Othoman Mellouk applauds civil society in Brazil.
  • Blatant manipulation: overpricing essential medicines

    Othoman Mellouk, describes some tactics used by companies to hike drug prices. He also highlights how civil society is fighting back. Othoman is ITPC’s Intellectual Property & Access to Medicines Expert. When I caught sight of the recent news that Germany’s patent court had granted a compulsory license for the manufacturing of a HIV drug, I celebrated. A compulsory license is a legal tool at governments disposal (included in national laws and authorized by international agreements and treaties). It allows them to suspend patent protection on a specific medicine and authorize someone other than the patent owner to produce a generic version of a medicine to address a public health problem. It makes essential, expensive, medicines more affordable. The scenario of over-priced drugs is so common, that you’d think compulsory licenses would be fairly standard. The case of Gilead charging between $4 and $1000 a day for the same medicine depending on the country ...

ITPC SPOTLIGHT

View all +
'Be healthy - know your viral load' film

'Be healthy - know your viral load' film

ITPC launches new Africa-wide campaign ‘Be Healthy – Know your viral load’ encouraging people living with HIV to get a viral load test, and demanding governments to provide routine viral load testing to all people living with HIV. Partnering with AIDS & Rights Alliance for Southern Africa (ARASA) and eleven national partners from across the region, the campaign got started with a march in Lusaka on 30 October. Check out the new website http://www.knowyourviralload.org/

Watch Video
Donate Now